These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19836653)

  • 81. Takotsubo syndrome in a patient treated with sunitinib for renal cancer.
    Numico G; Sicuro M; Silvestris N; Mozzicafreddo A; Trogu A; Malossi A; Cristofano A; Thiebat B
    J Clin Oncol; 2012 Aug; 30(24):e218-20. PubMed ID: 22802320
    [No Abstract]   [Full Text] [Related]  

  • 82. Sunitinib-induced scrotal cutaneous side-effect.
    Chou CY; Wang KH; Lin YH; Lin YT; Tsai HH
    J Dermatol; 2013 Jan; 40(1):67-8. PubMed ID: 23078345
    [No Abstract]   [Full Text] [Related]  

  • 83. [Gottron-like papules induced by sunitinib].
    Martorell-Calatayud A; Sanmartín O; Traves-Zapata V; Guillén C
    Actas Dermosifiliogr; 2011 Jun; 102(5):385-7. PubMed ID: 21481331
    [No Abstract]   [Full Text] [Related]  

  • 84. "Pseudocavitation" in thymic carcinoma during treatment with sunitinib.
    Tiseo M; Rajan A; Thomas A; Giaccone G
    J Thorac Oncol; 2013 Apr; 8(4):511-2. PubMed ID: 23486269
    [No Abstract]   [Full Text] [Related]  

  • 85. Kidney cancer: Intermittent sunitinib is an effective renal carcinoma treatment.
    Czarnecka AM
    Nat Rev Urol; 2017 May; 14(5):264-266. PubMed ID: 28266515
    [No Abstract]   [Full Text] [Related]  

  • 86. Case of sunitinib-induced Stevens-Johnson syndrome.
    Lee JH; Lee JH; Lee JH; Kim SY; Kim GM
    J Dermatol; 2013 Sep; 40(9):753-4. PubMed ID: 23855706
    [No Abstract]   [Full Text] [Related]  

  • 87. Acute renal failure during the "off" period after sunitinib administration: possible mechanism of vascular endothelial growth factor cascade hyperactivation.
    Kato T; Tomita Y; Watanabe T
    Int J Urol; 2013 Nov; 20(11):1149-50. PubMed ID: 23659419
    [No Abstract]   [Full Text] [Related]  

  • 88. Lung toxicity in a patient treated with sunitinib.
    Boyle HJ; Chatté G; Rivoire M; Fléchon A
    Eur Respir J; 2012 Nov; 40(5):1300-3. PubMed ID: 23115316
    [No Abstract]   [Full Text] [Related]  

  • 89. Risks associated with sunitinib use and monitoring to improve patient outcomes.
    Choi BS
    Korean J Intern Med; 2014 Jan; 29(1):23-6. PubMed ID: 24574829
    [No Abstract]   [Full Text] [Related]  

  • 90. Sunitinib-induced pyoderma gangrenosum-like skin ulcer.
    Kuntz T; Koushk-Jalali B; Kreuter A
    CMAJ; 2020 May; 192(20):E552. PubMed ID: 32452467
    [No Abstract]   [Full Text] [Related]  

  • 91. Hemorrhage caused by antiangiogenic therapy within previously irradiated areas: expected consequence of tumor shrinkage or a warning for antiangiogenic agents combined to radiotherapy?
    Soria JC; Deutsch E
    Ann Oncol; 2011 Jun; 22(6):1247-1249. PubMed ID: 21382869
    [No Abstract]   [Full Text] [Related]  

  • 92. Adjuvant sunitinib in renal cell carcinoma: from evidence to recommendation.
    Bex A
    Ann Oncol; 2017 Apr; 28(4):682-684. PubMed ID: 28104620
    [No Abstract]   [Full Text] [Related]  

  • 93. Are We Ready for Adjuvant Sunitinib in High-risk Renal Cell Carcinoma?
    Casuscelli J; Hsieh JJ
    Eur Urol; 2018 Jan; 73(1):69-70. PubMed ID: 29032154
    [No Abstract]   [Full Text] [Related]  

  • 94. Sporadic CNS hemangioblastomatosis, response to sunitinib and secondary polycythemia.
    Reyes-Botero G; Gállego Pérez-Larraya J; Sanson M
    J Neurooncol; 2012 Apr; 107(2):439-40. PubMed ID: 22076450
    [No Abstract]   [Full Text] [Related]  

  • 95. Erosive nappy erythema following sunitinib intake.
    Kharmoum S; Errihani H
    Pan Afr Med J; 2013; 14():46. PubMed ID: 23560129
    [No Abstract]   [Full Text] [Related]  

  • 96. Nonthrombocytopenic, noninflammatory simplex purpura during sunitinib therapy.
    García-Legaz Martínez M; Martínez-Doménech Á; Pérez-Pastor G; Magdaleno-Tapial J; Valenzuela-Oñate C; Alegre-de Miquel V; Pérez-Ferriols A
    Int J Dermatol; 2019 Aug; 58(8):e153-e155. PubMed ID: 30957224
    [No Abstract]   [Full Text] [Related]  

  • 97. Myelosuppression by sunitinib is flt-3 genotype dependent.
    van Erp NP; Mathijssen RH; van der Veldt AA; Haanen JB; Reyners AK; Eechoute K; Boven E; Wessels JA; Guchelaar HJ; Gelderblom H
    Br J Cancer; 2010 Aug; 103(5):757-8. PubMed ID: 20683446
    [No Abstract]   [Full Text] [Related]  

  • 98. Exfoliative Esophagitis Induced By Sunitinib.
    Nagata K; Akazawa Y
    Mayo Clin Proc; 2019 Mar; 94(3):557-558. PubMed ID: 30832801
    [No Abstract]   [Full Text] [Related]  

  • 99. Severe hypothyroidism presenting as myxedema coma in the postoperative period in a patient taking sunitinib: case report and review of literature.
    Lele AV; Clutter S; Price E; De Ruyter ML
    J Clin Anesth; 2013 Feb; 25(1):47-51. PubMed ID: 23246982
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Sunitinib Alone or after Nephrectomy in Renal Cancer.
    Bex A; Powles T; Haanen J
    N Engl J Med; 2018 Nov; 379(19):1877-8. PubMed ID: 30406978
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.